163,839 Healthpeak Properties, Inc. $DOC Shares Bought by Sumitomo Mitsui DS Asset Management Company Ltd

Sumitomo Mitsui DS Asset Management Company Ltd boosted its stake in shares of Healthpeak Properties, Inc. (NYSE:DOC) by 87.2% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 351,828 shares of the real estate investment trust’s stock after buying an additional 163,839 shares during the quarter. Sumitomo Mitsui DS Asset Management Company Ltd owned approximately 0.05% of Healthpeak Properties worth $7,026,000 as of its most recent SEC filing.

Other large investors also recently added to or reduced their stakes in the company. VIRGINIA RETIREMENT SYSTEMS ET Al bought a new stake in shares of Healthpeak Properties during the second quarter valued at approximately $3,837,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its holdings in shares of Healthpeak Properties by 20,832.8% in the second quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 6,217,474 shares of the real estate investment trust’s stock valued at $133,054,000 after purchasing an additional 6,187,772 shares during the period. Concurrent Investment Advisors LLC grew its stake in Healthpeak Properties by 70.7% in the second quarter. Concurrent Investment Advisors LLC now owns 63,838 shares of the real estate investment trust’s stock worth $1,366,000 after purchasing an additional 26,447 shares in the last quarter. NewEdge Advisors LLC grew its stake in Healthpeak Properties by 23.1% in the second quarter. NewEdge Advisors LLC now owns 146,336 shares of the real estate investment trust’s stock worth $3,132,000 after purchasing an additional 27,508 shares in the last quarter. Finally, Adelante Capital Management LLC bought a new position in Healthpeak Properties in the second quarter worth approximately $21,605,000. 93.57% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Several research analysts have commented on DOC shares. UBS Group reduced their price objective on Healthpeak Properties from $21.50 to $20.00 and set a “neutral” rating on the stock in a report on Tuesday, October 13th. Barclays decreased their target price on Healthpeak Properties from $24.00 to $21.00 and set an “equal weight” rating for the company in a research report on Tuesday, October 13th. Citigroup upped their target price on Healthpeak Properties from $20.00 to $22.00 and gave the stock a “neutral” rating in a report on Tuesday, August 11th. JPMorgan Chase & Co. upped their target price on Healthpeak Properties from $18.00 to $21.00 and gave the stock a “neutral” rating in a report on Wednesday, June 24th. Finally, Cantor Fitzgerald increased their price target on Healthpeak Properties from $20.00 to $23.00 and gave the stock a “neutral” rating in a research report on Thursday, August 6th. Four investment analysts have rated the stock with a Buy rating and fourteen have given a Hold rating to the stock. According to MarketBeat.com, Healthpeak Properties currently has a consensus rating of “Hold” and a consensus target price of $21.60.

Healthpeak Properties Stock Down 1.6%

Shares of Healthpeak Properties stock opened at $18.46 on Thursday. The company has a debt-to-equity ratio of 1.06, a current ratio of 3.02 and a quick ratio of 3.02. The stock has a market cap of $12.73 billion, a price-to-earnings ratio of 10.20, a PEG ratio of 2.32 and a beta of 1.01. The firm’s 50-day moving average is $20.13 and its two-hundred day moving average is $19.93. Healthpeak Properties, Inc. has a 1 year low of $15.70 and a 1 year high of $22.95.

Healthpeak Properties (NYSE:DOC) last posted its quarterly earnings results on Tuesday, August 4th. The real estate investment trust reported $0.08 EPS for the quarter, beating the consensus estimate of $0.03 by $0.05. Healthpeak Properties had a net margin of 8.24% and a return on equity of 2.79%. The business had revenue of $771.58 million during the quarter, compared to analyst estimates of $725.64 million. During the same quarter in the previous year, the business posted $0.46 EPS. The company’s quarterly revenue was up 11.1% compared to the same quarter last year. Healthpeak Properties has set its FY 2026 guidance at 1.730-1.770 EPS. As a group, research analysts expect that Healthpeak Properties, Inc. will post 1.77 earnings per share for the current fiscal year.

Healthpeak Properties Announces Dividend

The firm also recently disclosed a monthly dividend, which will be paid on Wednesday, December 30th. Stockholders of record on Friday, December 18th will be paid a dividend of $0.1017 per share. The ex-dividend date is Friday, December 18th. This represents a $1.22 dividend on an annualized basis and a dividend yield of 6.6%. Healthpeak Properties’s dividend payout ratio (DPR) is currently 348.57%.

Healthpeak Properties Profile

Healthpeak Properties, Inc (NYSE:DOC) is a real estate investment trust that owns, operates and develops healthcare-related real estate in the United States. The company primarily serves healthcare providers, research organizations and senior-care operators through a portfolio of specialized properties.

Its main activities include the ownership and leasing of outpatient medical office buildings, life science facilities and senior housing properties. These assets support services such as physician practices, ambulatory care, medical research and senior living.